Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Bayer Yakuhin said on August 11 that it has obtained approval for the OD tablet version of the anticoagulant Xarelto (rivaroxaban), which was developed specially for the Japanese market.The product is available in 10 mg and 15 mg versions. The…
To read the full story
Related Article
- Xarelto Now Available in OD Tablets, Japan-Specific Dosage Form
January 19, 2021
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





